Previously treated cases tested for RR-/MDR-TB (%) in Nigeria
Nigeria: Previously treated cases tested for RR-/MDR-TB was 95.0% in 2024. ◆ Volatile
Previously treated cases tested for RR-/MDR-TB in Nigeria, 2007–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Nigeria recorded 95.0% for previously treated cases tested for rr-/mdr-tb in 2024.
The figure is down 2.1% on the previous year and up 48.4% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Nigeria peaked at 100.0% in 2019 and was at its lowest, 0.2%, in 2010.
That places Nigeria 66th out of 180 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Previously treated cases tested for RR-/MDR-TB in Nigeria, year by year
| Year | Value | Change |
|---|---|---|
| 2007 | 0.7% | — |
| 2008 | 0.3% | -59.7% |
| 2009 | 0.3% | +14.8% |
| 2010 | 0.2% | -32.3% |
| 2011 | 0.9% | +309.5% |
| 2012 | 4.2% | +388.4% |
| 2015 | 64.0% | +1423.8% |
| 2016 | 71.0% | +10.9% |
| 2017 | 61.0% | -14.1% |
| 2018 | 88.0% | +44.3% |
| 2019 | 100.0% | +13.6% |
| 2020 | 91.0% | -9.0% |
| 2021 | 94.0% | +3.3% |
| 2022 | 97.0% | +3.2% |
| 2023 | 97.0% | +0.0% |
| 2024 | 95.0% | -2.1% |
Nigeria compared with similar countries
- Nigeria's 95.0% is above the median for lower middle income countries, which is 90.0%, 1.1× the median. (47 countries reporting)
- Nigeria's 95.0% is above the median for Sub-Saharan Africa, which is 91.5%, 1.0× the median. (46 countries reporting)
Biggest year-on-year movements
Years where Previously treated cases tested for RR-/MDR-TB in Nigeria changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2015 | +1423.8% | 4.2% | 64.0% |
| 2012 | +388.4% | 0.9% | 4.2% |
| 2011 | +309.5% | 0.2% | 0.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.4% | 0.3% | 0.7% | 3 |
| 2010s | 48.7% | 0.2% | 100.0% | 8 |
| 2020s | 94.8% | 91.0% | 97.0% | 5 |
Countries ranked near Nigeria
More health data for Nigeria
- Un projection of annual infant deaths, annual growth rate -1.08 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8137 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,301 deaths per 1,000 people (2090)
- Number of infants who die before age 1 257,921 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 1.14 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0711 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.17 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Nigeria?
- Previously treated cases tested for rr-/mdr-tb in Nigeria was 95.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Nigeria?
- The highest recorded value was 100.0% in 2019.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Nigeria?
- The lowest recorded value was 0.2% in 2010.
- How does Nigeria rank for previously treated cases tested for rr-/mdr-tb?
- Nigeria ranks 66th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Nigeria?
- Over the last ten years it is up 48.4%. The long-run trend across the full record is volatile.
- Where does this Nigeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).